Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: a case report

We report on the first successful treatment of severe pharmacoresistant vasoplegic syndrome with angiotensin II acetate (ATII) in Croatia. ATII is a novel drug used to treat severe vasoplegic shock resistant to the administration of catecholamines or alternative vasopressors such as vasopressin or m...

Descripción completa

Detalles Bibliográficos
Autores principales: Šribar, Andrej, Mikecin, Verica, Presečki, Ivana, Barić, Davor, Marijančević, Domagoj, Peršec, Jasminka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332295/
https://www.ncbi.nlm.nih.gov/pubmed/37391918
http://dx.doi.org/10.3325/cmj.2023.64.201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332295/
https://www.ncbi.nlm.nih.gov/pubmed/37391918
http://dx.doi.org/10.3325/cmj.2023.64.201

Ejemplares similares